|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/10/24 Manhattan Scientifics Inc. 8-K:5 4/09/24 12:126K Discount Edgar/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 20K 7: R1 Cover HTML 42K 9: XML IDEA XML File -- Filing Summary XML 13K 12: XML XBRL Instance -- mhtx_8k_htm XML 15K 8: EXCEL IDEA Workbook of Financial Report Info XLSX 8K 4: EX-101.CAL XBRL Calculations -- mhtx-20240409_cal XML 7K 6: EX-101.DEF XBRL Definitions -- mhtx-20240409_def XML 10K 3: EX-101.LAB XBRL Labels -- mhtx-20240409_lab XML 41K 5: EX-101.PRE XBRL Presentations -- mhtx-20240409_pre XML 27K 2: EX-101.SCH XBRL Schema -- mhtx-20240409 XSD 19K 10: JSON XBRL Instance as JSON Data -- MetaLinks 11± 16K 11: ZIP XBRL Zipped Folder -- 0001477932-24-001963-xbrl Zip 12K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest reported): i April 9, 2024
i MANHATTAN SCIENTIFICS, INC. |
(Exact name of registrant as specified in charter) |
i Delaware |
|
| i 85-0460639 | |
(State or Other Jurisdiction of Incorporation or Organization) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
i 244 Fifth Avenue, i Suite 2341
i New York, i New York i 10001
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: ( i 212) i 541-2405
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Not applicable.
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Not applicable. |
|
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On April 9, 2024, Frank Georgiou resigned as a member of the board of directors of Manhattan Scientifics, Inc. (the “Company”). Mr. Georgiou’s resignation was not the result of any disagreement with the Company. The Company would like to thank Frank for his many years of service. |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MANHATTAN SCIENTIFICS, INC. |
| |
|
|
|
|
Date: April 10, 2024 | By: |
| |
| Name: |
| |
| Title: | Chief Executive Officer |
|
| 3 |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/10/24 | None on these Dates | ||
| For Period end: | 4/9/24 | |||
| List all Filings | ||||